Learn about our extensive range of CGH + SNP microarrays dedicated to cytogenetic workflows. We provide whole genome CMA at variable resolutions, down to exon level, CGH+SNP arrays to analyze CN and LOH in a single experiment and application specific designs, including pre- post-natal, PGS, CNV and Cancer specific microarrays. Agilent’s CGH platform provides unmatched flexibility on content and throughput, thanks to eight different microarray formats with variable density and arrays per slide. Agilent provides a database of more than 28 million validated probes, and easy tools to customize array content based on needs. Custom or catalog, all Agilent’s CGH & CGH+SNP arrays benefit from proprietary SurePrint technology with long, high quality oligos.
The GenetiSure Cancer Research CGH+SNP microarray is designed to target cancer regions of the genome sourced from the COSMIC and CGC databases. Loss of heterozygosity (LOH) detection, with a resolution validated to 2.5 MB, ensures that important aberrations are not missed.
The Agilent CGH+SNP technology features exon-targeted probe content that allows for faster, more efficient association of aberrations with disease phenotypes. 89% of the exon is covered in the process. The CGC cancer array is optimized for CGH (comparative genomic hybridization) and CGH+SNP (Loss of heterozygosity) microarray workflows.